Skin rejuvenation without a scalpel. I. Fillers

Journal of Cosmetic Dermatology

Volumn 5, Issue 2, 2006, Pages 157-167

  Haneke, Eckart ^a,b  

^a UNIVERSITY OF FREIBURG   (Germany)

^b NONE   (Germany)

Author keywords

Collagen; Fat transplantation; Fillers; Human collagen; Hyaluronic acid; Rejuvenation; Side effects

Indexed keywords

BOTULINUM TOXIN A; COLLAGEN; COLLAGEN IMPLANT; FILLER; HYALURONIC ACID; POLY(METHYL METHACRYLATE); POLYLACTIC ACID; SUTURE MATERIAL;

ACNE; ADIPOSE TISSUE; AGING; ARTICLE; AUTOTRANSPLANTATION; BACTERIAL INFECTION; BODY FAT; DERMATOLOGY; ESTHETIC SURGERY; ESTHETICS; GRANULOMA; HERPES SIMPLEX; HERPES SIMPLEX VIRUS; HUMAN; INFLAMMATION; PRIORITY JOURNAL; RISK ASSESSMENT; SCALPEL; SKIN BRUISING; SKIN SCAR; TREATMENT INDICATION; TREATMENT OUTCOME; WASTING SYNDROME; WRINKLE;

BIOCOMPATIBLE MATERIALS; BOTULINUM TOXIN TYPE A; COLLAGEN; COSMETIC TECHNIQUES; DERMATOLOGIC AGENTS; HUMANS; HYALURONIC ACID; INJECTIONS; NEUROMUSCULAR AGENTS; SKIN AGING;

EID: 33745289096     PISSN: 14732130     EISSN: 14732165     Source Type: Journal    
DOI: 10.1111/j.1473-2165.2006.00243.x     Document Type: Article

References (51)

1. Matarasso SL, Glogau RG. Chemical face peels. Clin Dermatol 1991; 9: 131-50.
2. Matarasso SL, Hanke CW, Alster TS. Cutaneous resurfacing. Dermatol Clin 1997; 15: 569-82.
3. Haneke E. Soft tissue augmentation with injectable fillers and implants. In: H Vuyk, P Lohuisen, eds. European Facial Plastic Surgery. Hodder Arnold, London; 2006: 167-80.
4. Maas CS, Papel ID, Greene D et al. Complications of injectable synthetic polymers in facial augmentation. Dermatol Surg 1997; 23: 871-7.
5. Ciancio SJ, Coburn M. Penile salvage for squamous cell carcinoma associated with mineral oil injection. J Urol 2000; 164: 1650.
6. Wiest LG, Landthaler M, Stolz W. Hautaugmentation mit Polymethylmethacrylat. In: B Konz, B Wörle, CA Sander, eds. Ästhetische und korrektive Dermatologie. Fortschritte der operativen und onkologischen Dermatologie 14. Berlin: Blackwell WissVerl; 1999: Pp. 196-202.
7. Sherris DA, Gassner HG. Botulinum toxin to minimize facial scarring. Facial Plast Surg 2002; 18: 35-9.
8. Sclafani AP, Romo T III Collagen, human collagen, and fat: The search for a three-dimensional soft tissue filler. Facial Plast Surg 2001; 17: 79-85.
9. Cooperman LS, Mackinnon V, Bechler G et al. Injectable collagen: A six-year clinical investigation. Aesthetic Plast Surg 1985; 9: 145-51.
10. DeLustro F, Smith ST, Sundsmo J et al. Reaction to injectable collagen: results in animal models and clinical use. Plast Reconstr Surg 1987; 79: 581-94.
11. Elson ML. Clinical assessment of Zyplast implant: A year of experience for soft tissue contour correction. J Am Acad Dermatol 1988; 18: 707-13.
12. Klein AW. Guidelines of care for soft tissue augmentation. J Am Acad Dermatol 1996; 34: 690-4.
13. Klein AW, Wexler P, Carruthers A et al. Treatment of facial furrows and rhytides. Dermatol Clin 1997; 15: 595-607.
14. Fagien S. Botox for the treatment of dynamic and hyperkinetic facial lines and furrows: Adjunctive use in facial aesthetic surgery. Plast Reconstr Surg 1999; 103: 701-13.
15. Sclafani AP, Romo T, Jacono A et al. Evaluation of acellular dermal graft in sheet (Alloderm) and injectable (micronized Alloderm) forms for soft tissue augmentation: Clinical results and histologic findings. Arch Facial Plast Surg 2000; 2: 130-6.
16. Moody BR, Sengelmann RD. Self-limited adverse reaction to human-derived collagen injectable implant. Dermatol Surg 2000; 26: 936-8.
17. Klein AW. Commentary. Dermatol Surg 2000; 26: 938.
18. Sclafani AP, Romo T, Parker A et al. Evaluation of autologous collagen dispersion (Autologen) for soft tissue augmentation. Arch Facial Plast Surg 2000; 2: 48-52.
19. Gold MH. Fibrel. Dermatol Clin 1995; 13: 353-61.
20. Millikan L, Banks K, Purkait G et al. A five-year safety and efficacy evaluation with Fibrel in the correction of cutaneous scars following one or two treatments. J Dermatol Surg Oncol 1991; 17: 223-9.
21. Valantin MA, Aubron-Olivier C, Ghosn J, et al. Polylactic acid implants (NewFill) to correct facial lipoatrophy in HIV-infected patients: results of the open-label study VEGA. AIDS 2003; 17: 2471-7.
22. Moyle GJ, Lysakova L, Brown S, et al. A randomized open-label study of immediate versus delayed polylactic acid injections for the cosmetic management of facial lipoatrophy in persons with HIV infection. HIV Med 2004; 5: 82-7.
23. Wörle B, Hanke CW, Sattler G. Poly-L-lactic acid: A temporary filler for soft tissue augmentation. J Drugs Dermatol 2004; 3: 385-9.
24. Lowe NJ, Maxwell CA, Lowe P et al. Hyaluronic acid skin fillers: Adverse reactions and skin testing. J Am Acad Dermatol 2001; 45: 930-3.
25. Schuller-Petrovic S. Augmentationstechniken mit Kollagen und Hyaluronsäure. In: G Sebastian, A Stein, I Hackert, eds. Standards und Trends in der Operativen und Onkologischen Dermatologie, Phlebologie und Proktologie. Fortschritte der Operativen und Onkologischen Dermatologie 17. BerlinP Congress Compact Verl; 2001: pp. 31-6.
26. Olenius M. the first clinical study using a new biodegradable implant for the treatment of lips, wrinkles, and folds. Aesthetic Plast Surg 1998; 22: 97.
27. Manna F, Dentini M, Desideri P et al. Comparative chemical evaluation of two commercially available derivatives of hyaluronic acid (Hylaform from rooster combs and Restylane from Streptococcus) used for soft tissue augmentation. J Eur Acad Dermatol Venereol 1999; 13: 183-92.
28. Lexer E. Freie Fettgewebstransplantation. Dtsch Med Wschr 1910; 36: 640.
29. Coleman WP III, Lawrence N, Sherman RN et al. Autologous collagen? Lipocytic dermal augmentation. A histopathologic study. J Dermatol Surg Oncol 1993; 19: 1032-40.
30. Coleman SR. Facial recontouring with lipostructure. Clin Plast Surg 1997; 24: 347-67.
31. Illouz YG. Present results of fat injection. Aesthetic Plast Surg 1988; 12: 175-81.
32. Pinski KS, Roenigk HH. Autologous fat transplantation: Long-term follow-up. J Dermatol Surg Oncol 1992; 18: 179-84.
33. Schuller-Petrovic S. Lipofilling: Technik und Langzeitergebnisse. In: B Konz, B Wörle, CA Sander, eds. Ästhetische und Korrektive Dermatologie. Fortschritte der Operativen und Onkologischen Dermatologie 14. Berlin: BlackwelP WissVerl; 1999: pp. 191-5.
34. Klein AW. Dermal fat augmentation: A reality. J Dermatol Surg Oncol 1993; 19: 1030.
35. Sommer B, Sattler G. Eigenfett zur Augmentation. Histologische und klinische Studien zur Langlebigkeit -eine Übersicht. In: G Sebastian, A Stein, I Hackert, eds. Standards und Trends in der Operativen und Onkologischen Dermatologie, Phlebologie und Proktologie. Fortschritte der Operativen und Onkologischen Dermatologie 17. Berlin: Congress Compact Verl; 2001: Pp. 37-44.
36. Boschert MT, Beckert BW, Puckett CL et al. Analysis of lipocyte viability after liposuction. Plast Reconstr Surg 2002; 109: 761-5.
37. Eremia S, Newman N. Long-term follow-up after autologous fat grafting: analysis of results from 116 patients followed at least 12 months after receiving the last of a minimum of two treatments. Dermatol Surg 2000; 26: 1150-8.
38. Miller PJ, Levine J, Ahn MS, Maas CS, Constantinides M. Softform for facial rejuvenation: Historical review, operative techniques, and recent advances. Facial Plast Surg 2000; 16: 23-8.
39. Erol OO. Facial autologous soft-tissue contouring by adjunction of tissue cocktail injection (micrograft and minigraft mixture of dermis, fascia, and fat). Plast Reconstr Surg 2001; 106: 1375-87.
40. Blugerman G, Goldman MP. Autologous vein transplantation for correction of dermal atrophic changes. Dermatol Surg 2002; 28: 372-5.
41. Bigata X, Ribera M, Bielsa I et al. Adverse granulomatous reaction after cosmetic dermal silicone injection. Dermatol Surg 2001; 27: 198-200.
42. Faure M. Complications des implants de silicone et autres matériaux dits inertes. Ann Dermatol Venereol 1995; 122: 455-9.
43. Barnett JG. Injectable silicone in dermatologic surgery. Abstract. Cosmoderm 2 - Laserderm 1, Trieste, Italy, 31 Aug-3 Sept 2002.
44. Webster RC, Fuleihan NS, Hamdan US et al. Injectable silicone: Report of 17,000 facial treatments since 1962. Am J Cosmet Surg 1986; 3: 41-8.
45. Jones DH, Carruthers A, Orentreich D, et al. Highly purified 1000-cSt silicone oil for treatment of human immunodeficiency virus-associated facial lipoatrophy: An open pilot trial. Dermatol Surg 2004; 30: 1279-86.
46. Lemperle G, Hazan-Gauthier N, Lemperle M. PMMA microspheres (Artecoll) for skin and soft tissue augmentation. II. Clinical investigations. Plast Reconstr Surg 1995; 96: 627-34.
47. Lemperle G, Hazan-Gauthier N, Lemperle M. PMMA microspheres (Artecoll) for long-lasting correction of wrinkles: Refinements and statistical results. Aesthetic Plast Surg 1998; 22: 356-65.
48. Wiest L. Wann sind welche Behandlungsmethoden für welche Falten sinnvoll? In: G Sebastian, A Stein, I Hackert, eds. Standards und Trends in der operativen und onkologischen Dermatologie, Phlebologie und Proktologie. Fortschritte der Operativen und Onkologischen Dermatologie 17. Berlin: Congress CoPpact Verl; 2001: pp. 17-24.
49. Sulamanidze MA, Fournier PF, Paikidze TG et al. Removal of facial soft tissue ptosis with special threads. Dermatol Surg 2002; 28: 367-71.
50. Lycka B, Bazan C, Poletti E et al. The emerging technique of the antiptosis subdermal suspension thread. Dermatol Surg 2004; 30: 41-4.
51. Lemperle G, Morhenn V, Charrier U. Human histology and persistence of various injectable filler substances for soft tissue augmentation. Aesthetic Plast Surg 2003; 27: 354-66.